TY - JOUR
T1 - Four-repeat tauopathies
AU - Rösler, Thomas W.
AU - Tayaranian Marvian, Amir
AU - Brendel, Matthias
AU - Nykänen, Niko Petteri
AU - Höllerhage, Matthias
AU - Schwarz, Sigrid C.
AU - Hopfner, Franziska
AU - Koeglsperger, Thomas
AU - Respondek, Gesine
AU - Schweyer, Kerstin
AU - Levin, Johannes
AU - Villemagne, Victor L.
AU - Barthel, Henryk
AU - Sabri, O.
AU - Müller, Ulrich
AU - Meissner, Wassilios G.
AU - Kovacs, Gabor G.
AU - Höglinger, Günter U.
N1 - Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/9
Y1 - 2019/9
N2 - Tau is a microtubule-associated protein with versatile functions in the dynamic assembly of the neuronal cytoskeleton. Four-repeat (4R-) tauopathies are a group of neurodegenerative diseases defined by cytoplasmic inclusions predominantly composed of tau protein isoforms with four microtubule-binding domains. Progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease or glial globular tauopathy belong to the group of 4R-tauopathies. The present review provides an introduction in the current concept of 4R-tauopathies, including an overview of the neuropathological and clinical spectrum of these diseases. It describes the genetic and environmental etiological factors, as well as the contemporary knowledge about the pathophysiological mechanisms, including post-translational modifications, aggregation and fragmentation of tau, as well as the role of protein degradation mechanisms. Furthermore, current theories about disease propagation are discussed, involving different extracellular tau species and their cellular release and uptake mechanisms. Finally, molecular diagnostic tools for 4R-tauopathies, including tau-PET and fluid biomarkers, and investigational therapeutic strategies are presented. In summary, we report on 4R-tauopathies as overarching disease concept based on a shared pathophysiological concept, and highlight the challenges and opportunities on the way towards a causal therapy.
AB - Tau is a microtubule-associated protein with versatile functions in the dynamic assembly of the neuronal cytoskeleton. Four-repeat (4R-) tauopathies are a group of neurodegenerative diseases defined by cytoplasmic inclusions predominantly composed of tau protein isoforms with four microtubule-binding domains. Progressive supranuclear palsy, corticobasal degeneration, argyrophilic grain disease or glial globular tauopathy belong to the group of 4R-tauopathies. The present review provides an introduction in the current concept of 4R-tauopathies, including an overview of the neuropathological and clinical spectrum of these diseases. It describes the genetic and environmental etiological factors, as well as the contemporary knowledge about the pathophysiological mechanisms, including post-translational modifications, aggregation and fragmentation of tau, as well as the role of protein degradation mechanisms. Furthermore, current theories about disease propagation are discussed, involving different extracellular tau species and their cellular release and uptake mechanisms. Finally, molecular diagnostic tools for 4R-tauopathies, including tau-PET and fluid biomarkers, and investigational therapeutic strategies are presented. In summary, we report on 4R-tauopathies as overarching disease concept based on a shared pathophysiological concept, and highlight the challenges and opportunities on the way towards a causal therapy.
KW - 4R-tauopathy
KW - Alzheimer's disease
KW - Argyrophilic grain disease
KW - Corticobasal degeneration
KW - Glial globular tauopathy
KW - Microtubule-Associated protein tau
KW - Progressive supranuclear palsy
UR - http://www.scopus.com/inward/record.url?scp=85068011645&partnerID=8YFLogxK
U2 - 10.1016/j.pneurobio.2019.101644
DO - 10.1016/j.pneurobio.2019.101644
M3 - Review article
C2 - 31238088
AN - SCOPUS:85068011645
SN - 0301-0082
VL - 180
JO - Progress in Neurobiology
JF - Progress in Neurobiology
M1 - 101644
ER -